Bio-Path Holdings, Inc. (BPTH) Social Stream
BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BPTH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-14 | 1 | $13 | $12 | $12.5 | $2.07 | 503.86% |
| 2022-05-17 | 2 | $13 | $12 | $12.5 | $2.07 | 503.86% |
| 2022-11-15 | 2 | $13 | $9 | $11 | $2.07 | 431.4% |
The Trend in the Analyst Price Target
BPTH's average price target has moved down $7 over the prior 30 months.
BPTH reports an average of 327.99% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-14 | 1 | 13 | 12 | 12.5 | 3.06 | 308.5% |
| 2022-05-17 | 2 | 13 | 12 | 12.5 | 3.11 | 301.93% |
| 2022-05-18 | 2 | 13 | 9 | 11.0 | 3.11 | 253.7% |
| 2022-08-17 | 2 | 13 | 9 | 11.0 | 3.94 | 179.19% |
| 2022-11-15 | 2 | 13 | 9 | 11.0 | 1.53 | 618.95% |
BPTH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BPTH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.
- BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 6.9% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, BIO-PATH HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 279.17% of them.
- In terms of how BIO-PATH HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 65.51% of that group.
- BIO-PATH HOLDINGS INC's average analyst price target is greater than 67.28% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIO-PATH HOLDINGS INC are GALT, ONTX, and LUMO.
View All Top Stocks by Price Target
Make investment decisions regarding BPTH using the data that counts. Try POWR Ratings for free.